Rankings
▼
Calendar
ONC Q3 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$32B
Q3 2017 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$220M
Gross Profit
$131M
59.3% margin
Operating Income
$115M
52.2% margin
Net Income
$117M
53.3% margin
EPS (Diluted)
$2.60
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
-$12M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$285M
Stockholders' Equity
$750M
Cash & Equivalents
$209M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$220M
$0
—
Gross Profit
$131M
-$30M
+533.8%
Operating Income
$115M
-$35M
+429.9%
Net Income
$117M
-$35M
+430.7%
← FY 2017
All Quarters
Q4 2017 →